# Sample Recruitment Templates by Therapeutic Area

## Template 1: Oncology (Phase II Immunotherapy)

```
================================================================================
RESEARCH STUDY: New Treatment Option for Advanced [Cancer Type]
================================================================================

ABOUT THIS STUDY
----------------------------------------
We are conducting research to evaluate an investigational immunotherapy for 
people with advanced [cancer type] that has progressed after standard treatment. 
This study drug works by helping your immune system recognize and attack cancer 
cells. Your participation may help advance cancer treatment options.

WHO CAN PARTICIPATE
----------------------------------------
You may be eligible if you:
- Are 18 years or older with advanced [cancer type]
- Have disease progression after prior therapy
- Have adequate organ function
- Are willing to follow study procedures

Not everyone who volunteers will qualify. A screening visit will determine 
eligibility.

WHAT'S INVOLVED
----------------------------------------
If you qualify and choose to participate:
- Time commitment: Up to 24 months, with visits every 2-3 weeks
- You will receive: Investigational immunotherapy by IV infusion
- Regular scans to monitor disease status
- All study-related procedures and visits are provided at no cost
- Optional tumor biopsy at baseline

Detailed information will be provided before you decide to participate.

RISKS AND BENEFITS
----------------------------------------
- The study treatment may or may not benefit you directly
- Potential side effects include fatigue, rash, diarrhea, and immune-related 
  reactions (full list will be provided)
- You will be closely monitored for any adverse effects
- Your participation may contribute to cancer research that helps others
- Standard cancer treatments remain available to you

YOUR RIGHTS
----------------------------------------
- Participation is completely voluntary
- You may withdraw from the study at any time without penalty
- Your decision will not affect your regular medical care
- Your personal information will be kept confidential
- The study is reviewed by an Institutional Review Board (IRB #: XXXX-XXXX)
- You will receive complete information before giving consent

CONTACT US
----------------------------------------
Principal Investigator: Dr. [Name], [Credentials]
Location: [Medical Center, Department]
Contact: [Phone] or [Email]

Questions about your rights as a research participant? Contact the IRB at the 
number provided in the full informed consent document.

================================================================================
```

---

## Template 2: Diabetes (Phase III Oral Medication)

```
================================================================================
Clinical Study for Type 2 Diabetes: Volunteers Needed
================================================================================

ABOUT THIS STUDY
----------------------------------------
We are conducting Phase III research to evaluate a new oral medication for 
Type 2 diabetes management. This study compares the investigational medication 
to a standard treatment to assess its effectiveness and safety. Your 
participation may help improve future diabetes care.

WHO CAN PARTICIPATE
----------------------------------------
You may be eligible if you:
- Are 18-70 years old with Type 2 diabetes
- Currently on metformin or diet/exercise alone
- HbA1c between 7.0% and 10.5%
- Are willing to follow study procedures

Not everyone who volunteers will qualify. A screening visit will determine 
eligibility.

WHAT'S INVOLVED
----------------------------------------
If you qualify and choose to participate:
- Time commitment: 52 weeks, with 12 clinic visits
- You will receive: Study medication (investigational or standard care)
- Blood sugar monitoring supplies provided
- Diabetes education and counseling
- All study-related procedures and visits are provided at no cost

Detailed information will be provided before you decide to participate.

RISKS AND BENEFITS
----------------------------------------
- The study medication may or may not improve your diabetes control
- Potential side effects include nausea, stomach upset, and low blood sugar 
  (full list will be provided)
- You will be closely monitored for any adverse effects
- Your participation may contribute to diabetes research that helps others
- Your current diabetes treatment remains available to you

YOUR RIGHTS
----------------------------------------
- Participation is completely voluntary
- You may withdraw from the study at any time without penalty
- Your decision will not affect your regular medical care
- Your personal information will be kept confidential
- The study is reviewed by an Institutional Review Board (IRB #: XXXX-XXXX)
- You will receive complete information before giving consent

COMPENSATION
----------------------------------------
You may receive $50 per completed visit ($600 total) for your time and travel. 
Details will be provided during the informed consent process.

CONTACT US
----------------------------------------
Principal Investigator: Dr. [Name], Endocrinology
Location: [Diabetes Research Center]
Contact: [Phone] or [Email]

Questions about your rights as a research participant? Contact the IRB at the 
number provided in the full informed consent document.

================================================================================
```

---

## Template 3: Cardiology (Phase I Device Study)

```
================================================================================
Research Study: New Heart Monitoring Device
================================================================================

ABOUT THIS STUDY
----------------------------------------
We are conducting early-stage research to evaluate the safety of a new 
implantable heart monitoring device. This device is designed to continuously 
monitor heart rhythm and detect irregularities. Your participation will help 
advance cardiac monitoring technology.

WHO CAN PARTICIPATE
----------------------------------------
You may be eligible if you:
- Are 21-75 years old
- Have documented cardiac arrhythmia
- Require long-term cardiac monitoring
- Are willing to follow study procedures

Not everyone who volunteers will qualify. A screening visit will determine 
eligibility.

WHAT'S INVOLVED
----------------------------------------
If you qualify and choose to participate:
- Time commitment: 6 months, with monthly follow-up visits
- You will receive: Implantation of investigational monitoring device
- Regular device checks and monitoring
- All study-related procedures and visits are provided at no cost
- Device removal at study completion if desired

Detailed information will be provided before you decide to participate.

RISKS AND BENEFITS
----------------------------------------
- The device may or may not benefit your heart monitoring
- Potential risks include infection, bleeding, and device malfunction 
  (full list will be provided)
- You will be closely monitored for any adverse effects
- Your participation may contribute to cardiac device research that helps others
- Standard cardiac monitoring remains available to you

YOUR RIGHTS
----------------------------------------
- Participation is completely voluntary
- You may withdraw from the study at any time without penalty
- Your decision will not affect your regular medical care
- Your personal information will be kept confidential
- The study is reviewed by an Institutional Review Board (IRB #: XXXX-XXXX)
- You will receive complete information before giving consent

CONTACT US
----------------------------------------
Principal Investigator: Dr. [Name], Cardiology
Location: [Cardiac Center]
Contact: [Phone] or [Email]

Questions about your rights as a research participant? Contact the IRB at the 
number provided in the full informed consent document.

================================================================================
```

---

## Template 4: Pediatrics (Vaccine Study)

```
================================================================================
Research Study: New Vaccine for Children
================================================================================

ABOUT THIS STUDY
----------------------------------------
We are conducting research to evaluate a new vaccine for children to help 
protect against [disease]. This study will assess how well the vaccine works 
and how safe it is in children. Your child's participation may help advance 
vaccine development.

WHO CAN PARTICIPATE
----------------------------------------
Your child may be eligible if they:
- Are 6 months to 5 years old
- Are in good general health
- Have received routine childhood vaccines
- Parent/guardian willing to follow study procedures

Not every child who volunteers will qualify. A screening visit will determine 
eligibility.

WHAT'S INVOLVED
----------------------------------------
If your child qualifies and you choose to participate:
- Time commitment: 12 months, with 6 clinic visits
- Your child will receive: Study vaccine or placebo (randomly assigned)
- Monitoring for any reactions
- All study-related procedures and visits are provided at no cost
- Blood samples at select visits

Detailed information will be provided before you decide to participate.

RISKS AND BENEFITS
----------------------------------------
- The vaccine may or may not protect against [disease]
- Potential side effects include fever, soreness at injection site, and 
  fussiness (full list will be provided)
- Your child will be closely monitored for any adverse effects
- Your child's participation may contribute to vaccine research that helps others
- Standard childhood vaccines remain available

YOUR RIGHTS
----------------------------------------
- Participation is completely voluntary
- You may withdraw your child from the study at any time without penalty
- Your decision will not affect your child's regular medical care
- Your child's information will be kept confidential
- The study is reviewed by an Institutional Review Board (IRB #: XXXX-XXXX)
- You will receive complete information before giving consent

COMPENSATION
----------------------------------------
You may receive $75 per completed visit ($450 total) for your time and travel. 
Details will be provided during the informed consent process.

CONTACT US
----------------------------------------
Principal Investigator: Dr. [Name], Pediatrics
Location: [Children's Research Center]
Contact: [Phone] or [Email]

Questions about your rights as a research participant? Contact the IRB at the 
number provided in the full informed consent document.

================================================================================
```

---

## Key Compliance Notes for All Templates

1. **IRB Approval Required** - All recruitment materials must be reviewed and 
   approved by your IRB/EC before use.

2. **Accuracy Verification** - Ensure all details match your approved protocol.

3. **No Therapeutic Misconception** - Avoid language that implies the 
   investigational product is better than standard care.

4. **Avoid Coercion** - No "limited time" offers or pressure tactics.

5. **Respectful Language** - Use person-first language ("people with diabetes" 
   not "diabetics").

6. **Contact Information** - Always include IRB contact for questions about 
   participant rights.
